Ingevity Corp
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
NGVT$60.78-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income (Loss)
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| In millions | 2026 | 2025 |
| Net income (loss) | $59.8 | $20.5 |
| Other comprehensive income (loss), net of tax: | ||
| Foreign currency adjustments: | ||
| Foreign currency translation adjustment | (2.7) | 17.2 |
| Total foreign currency adjustments, net of tax provision (benefit) of zero for all periods | (2.7) | 17.2 |
| Derivative instruments: | ||
| Unrealized gain (loss), net of tax provision (benefit) of $0.1 and zero | 0.4 | 0.1 |
| Reclassifications of deferred derivative instruments (gain) loss, included in net income (loss), net of tax (provision) benefit of $0.1 and $0.1 | 0.2 | 0.1 |
| Total derivative instruments, net of tax provision (benefit) of $0.2 and $0.1 | 0.6 | 0.2 |
| Other comprehensive income (loss), net of tax provision (benefit) of $0.2 and $0.1 | (2.1) | 17.4 |
| Comprehensive income (loss) | $57.7 | $37.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.